anti-ELOVL6 antibody product blogThe ELOVL6 elovl6 (Catalog #MBS624731) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The ELOVL6, NT (Elongation of Very Long Chain Fatty Acids Protein 6, Fatty Acid Elongase 2, hELO2, Fatty Acyl-CoA Elongase, Long-chain Fatty-acyl Elongase, LCE, FACE) reacts with Human, Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s ELOVL6 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).
Suitable for use in ELISA and Western Blot.
Dilution: ELISA: 1:1,000
Western Blot: 1:50-1:100. Researchers should empirically determine the suitability of the ELOVL6 elovl6 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The ELOVL6 elovl6 product has the following accession number(s) (GI #195539343) (NCBI Accession #NP_001124193.1) (Uniprot Accession #Q9H5J4). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
ELOVL6, NT (Elongation of Very Long Chain Fatty Acids Protein 6, Fatty Acid Elongase 2, hELO2, Fatty Acyl-CoA Elongase, Long-chain Fatty-acyl Elongase, LCE, FACE)
Fatty acid elongases (EC 126.96.36.199), such as ELOVL6, use malonyl-CoA as a 2-carbon donor in the first and rate-limiting step of fatty acid elongation.
Immunogen: Synthetic peptide selected from the N-terminal region of human ELOVL6 (KLH). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ELOVL6 are readily searchable from our website. Different antibodies against the same target such as ELOVL6 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene. Body Weight Changes, Diabetes Mellitus, Fatty Liver, Hyperglycemia, Hyperinsulinism, Inflammation, Insulin Resistance, Liver Diseases, Neoplasms, Obesity are some of the diseases may be linked to ELOVL6, NT (Elongation of Very Long Chain Fatty Acids Protein 6, Fatty Acid Elongase 2, hELO2, Fatty Acyl-CoA Elongase, Long-chain Fatty-acyl Elongase, LCE, FACE). Adipose Tissue, Blood, Connective Tissue, Eye, Liver, Mammary Gland, Muscle, Pancreas, Testis, Vascular tissues are correlated with this protein.